KCI등재
SCOPUS
SCIE
Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus
저자
Hamoda Taha (Department of Urology, King Abdulaziz University, Jeddah, Saudi Arabia.Department of Urology, Minia University, Minia, Egypt.Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.) ; Shah Rupin (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Lilavati Hospital) ; Mostafa Taymour (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology, Sexology and STIs, Cairo University, Cairo, Egypt.) ; Pinggera Germar-Michael (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Medical University Innsbruck, Innsbruck, Austria.) ; Atmoko Widi (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia.) ; Rambhatla Amarnath (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Vattikuti Urology Institute, Henry Ford Health, Detroit, MI, USA.College of Human Medicine, Michigan State University, Lansing, MI, USA.) ; Al Hashimi Manaf (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Burjeel Hospital, Abu Dhabi, UAE.Department of Urology, Khalifa University – College of Medicine and Health Science, Abu Dhabi, UAE.) ; Çayan Selahittin (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, University of Mersin School of Medicine, Mersin, Türkiye.) ; Colpi Giovanni Maria (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Andrology and IVF Center, Next Fertility Procrea, Lugano, Switzerland.) ; Alipour Hiva (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Health Science and Technology, Aalborg University, Aalborg, Denmark.) ; Ko Edmund Y. (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Kaiser Permanente, Fontana, CA, USA.) ; Zini Armand (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Surgery, McGill University, Montreal, Canada.) ; Dimitriadis Fotios (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Aristotle University, Thessaloniki, Greece.) ; Rashed Ayman (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, October 6th University, 6th of October City, Egypt.) ; Park Hyun Jun (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Pusan National University School of Medicine, Busan, Korea.Medical Research Institute, Pusan National University Hospital, Busan, Korea.) ; Saleh Ramadan (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Dermatology, Venereology and Andrology, Sohag University, Sohag, Egypt.Ajyal IVF Center, Ajyal Hospital, Sohag, Egypt.) ; Toprak Tuncay (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, University of Health Sciences, Hamidiye Faculty of Medicine, FSM Health Practice) ; Ryzhkov Aleksei (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology with Nephrology, Yaroslavl State Medical University, Yaroslavl, Russia.) ; Kadıoğlu Ateş (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Istanbul University, Istanbul, Türkiye.) ; Kandil Hussein (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Fakih IVF Fertility Center, Abu Dhabi, UAE.Department of Urology, First IVF Fertility Center, Abu Dhabi, UAE.) ; Kalkanli Arif (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Medical Park Gebze Hospital, Kocaeli, Türkiye.) ; El-Sakka Ahmed I. (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Suez Canal University, Ismailia, Egypt.) ; Calik Gokhan (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Istanbul Medipol University, Istanbul, Türkiye.) ; Falcone Marco (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.SC Urologia U - SSD Neurourologia, University of Torino, Torino, Italy.Department of Urology, Biruni University, Istanbul, Türkiye.) ; Elbardisi Haitham (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Hamad Medical Corporation, Doha, Qatar.Department of Urology, College of Medicine, Qatar University, Doha, Qatar.Department of Urology, Weill Cornell Medi) ; Arafa Mohamed (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology, Sexology and STIs, Cairo University, Cairo, Egypt.Department of Urology, Hamad Medical Corporation, Doha, Qatar.Department of Urology, Weill Cornell Med) ; Ho Christopher Chee Kong (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Surgery, Taylor’s University, Kuala Lumpur, Malaysia.) ; Martinez Marlon Pedrozo (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Section of Urology, University of Santo Tomas Hospital, Manila, Philippines.) ; Binsaleh Saleh (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Surgery, Section of Urology, King Saud University, Riyadh, Saudi Arabia.) ; Motawi Ahmad Tarek (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology, Sexology and STIs, Cairo University, Cairo, Egypt.) ; Gherabi Nazim (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Medicine, Algiers 1 University, Algiers, Algeria.) ; Tsujimura Akira (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Juntendo University Urayasu Hospital, Urayasu, Japan.) ; Taniguchi Hisanori (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, Japan.) ; Kosgi Raghavender (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology) ; Calogero Aldo E. (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.) ; Shatylko Taras (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Andrology and Urology Department, V.I. Kulakov National Medical Research Center, Moscow, Russia.) ; Kim Dongsuk (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, CHA Gangnam Medical Center, CHA University, Seoul, Korea.) ; Thomas Charalampos (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, General Hospital of Corinth, Corinth, Greece.) ; Tadros Nicholas N. (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.) ; Andreadakis Sotiris (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, University of Ioannina, Ioannina, Greece.) ; Musa Muhammad Ujudud (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Urology Unit, Department of Surgery, Federal Teaching Hospital Katsina Nigeria, Katsina, Nigeria.Urology Unit, Department of Surgery, Al-Mithnab General Hospital Qasim Region, A) ; Konstantinidis Charalampos (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Urology) ; Preto Mirko (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, A.O.U Città della Salute e della Scoenza di Torino, Turin, Italy.) ; Le Tan V. (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology, Binh Dan Hospital, Ho Chi Minh City, Vietnam.Department of Andrology and Nephro-Urology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietn) ; Khalafalla Kareim Mohamed (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Urology, Hamad Medical Corporation, Doha, Qatar.Department of Urology, College of Medicine, Qatar University, Doha, Qatar.) ; Cannarella Rossella (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.Glickman Urological) ; Bowa Kasonde (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Clinical Sciences, University of Lusaka, Lusaka, Zambia.) ; Balagobi Balasingam (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Surgery, University of Jaffna, Jaffna, Sri Lanka.) ; Katz Darren Jonathan (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Men’s Health Melbourne Clinic, Melbourne, Australia.Department of Surgery, Western Precinct, University of Melbourne, Melbourne, Australia.Department of Urology, Western Health) ; Nguyen Quang (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Center for Andrology and Sexual Medicine, Viet Duc University Hospital, Hanoi, Vietnam.Department of Urology, Andrology and Sexual Medicine, University of Medicine and Pharmacy,) ; Tanwar Raman (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Department of Andrology, Centre for Reproductive Assistance, Andrology and Fertility, Gurugram, India.) ; Borges Edson (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Urology Section, Fertility Medical Group, São Paulo, Brazil.) ; Agarwal Ashok (Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA.Cleveland Clinic, Cleveland, OH, USA.)
발행기관
학술지명
The World Journal of Men's Health(The World Journal of Men's Health)
권호사항
발행연도
2026
작성언어
English
주제어
등재정보
KCI등재,SCOPUS,SCIE
자료형태
학술저널
발행기관 URL
수록면
90-105(16쪽)
DOI식별코드
제공처
Purpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure, is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can globally help guide practitioners in their practice.
Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, diagnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.” Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.” Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, including 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experience in managing NOA.
Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly integrated into the daily global practice, offering practitioners a clear framework for managing NOA.
분석정보
서지정보 내보내기(Export)
닫기소장기관 정보
닫기권호소장정보
닫기오류접수
닫기오류 접수 확인
닫기음성서비스 신청
닫기음성서비스 신청 확인
닫기이용약관
닫기학술연구정보서비스 이용약관 (2017년 1월 1일 ~ 현재 적용)
| 주요 개정내역 | 변경 사유 |
|---|---|
| · 수탁업체 콘소시엄 기관명 및 위탁기간 명시 | · 제6조(개인정보 처리업무의 위탁) 구체화 |
한국교육학술정보원은 정보주체의 자유와 권리 보호를 위해 「개인정보 보호법」 및 관계 법령이 정한 바를 준수하여, 적법하게 개인정보를 처리하고 안전하게 관리하고 있습니다. 이에 「개인정보 보호법」 제30조에 따라 정보주체에게 개인정보 처리에 관한 절차 및 기준을 안내하고, 이와 관련한 고충을 신속하고 원활하게 처리할 수 있도록 하기 위하여 다음과 같이 개인정보 처리방침을 수립·공개합니다.
주요 개인정보 처리 표시(라벨링)
목 차
제1조(개인정보의 처리 목적)
제2조(개인정보의 처리 및 보유 기간)
제3조(처리하는 개인정보의 항목)
제4조(개인정보파일 등록 현황)
제5조(개인정보의 제3자 제공)
제6조(개인정보 처리업무의 위탁)
제7조(개인정보의 파기 절차 및 방법)
제8조(정보주체와 법정대리인의 권리·의무 및 그 행사 방법)
제9조(개인정보의 안전성 확보조치)
제10조(개인정보 자동 수집 장치의 설치·운영 및 거부)
제11조(개인정보 보호책임자)
제12조(개인정보의 열람청구를 접수·처리하는 부서)
제13조(정보주체의 권익침해에 대한 구제방법)
제14조(추가적 이용·제공 판단기준)
제15조(개인정보 처리방침의 변경)
제1조(개인정보의 처리 목적)
제2조(개인정보의 처리 및 보유 기간)
3년
또는 회원탈퇴시까지5년
(「전자상거래 등에서의 소비자보호에 관한3년
(「전자상거래 등에서의 소비자보호에 관한2년
이상(개인정보보호위원회 : 개인정보의 안전성 확보조치 기준)
제3조(처리하는 개인정보의 항목)
제4조(개인정보파일 등록 현황)
개인정보파일 검색(privacy.go.kr)| 개인정보파일의 명칭 | 운영근거 / 처리목적 | 개인정보파일에 기록되는 개인정보의 항목 |
보유기간 | |
|---|---|---|---|---|
| 학술연구정보서비스 이용자 가입정보 | 한국교육학술정보원법 정보추제 동의 | 필수 | ID, 비밀번호, 성명, 생년월일, 신분(직업구분), 이메일, 소속분야, 웹진메일 수신동의 여부 | 3년 또는 탈퇴시 |
| 선택 | 소속기관명, 소속도서관명, 학과/부서명, 학번/직원번호, 휴대전화, 주소 | |||
제5조(개인정보의 제3자 제공)
제6조(개인정보 처리업무의 위탁)
제7조(개인정보의 파기 절차 및 방법)
제8조(정보주체와 법정대리인의 권리·의무 및 그 행사 방법)
제9조(개인정보의 안전성 확보조치)
제10조(개인정보 자동 수집 장치의 설치·운영 및 거부)
제11조(개인정보 보호책임자)
| 구분 | 담당자 | 연락처 |
|---|---|---|
| KERIS 개인정보 보호책임자 | 정보보호본부 안재호 |
- 이메일 : jinuk@keris.or.kr - 전화번호 : 053-714-0158 - 팩스번호 : 053-714-0195 |
| KERIS 개인정보 보호담당자 | 개인정보보호부 송진욱 | |
| RISS 개인정보 보호책임자 | 교육학술데이터본부 정광훈 |
- 이메일 : giltizen@keris.or.kr - 전화번호 : 053-714-0149 - 팩스번호 : 053-714-0194 |
| RISS 개인정보 보호담당자 | 학술진흥부 길원진 |
제12조(개인정보의 열람청구를 접수·처리하는 부서)
제13조(정보주체의 권익침해에 대한 구제방법)
제14조(추가적인 이용ㆍ제공 판단기준)
제15조(개인정보 처리방침의 변경)
자동로그아웃 안내
닫기인증오류 안내
닫기귀하께서는 휴면계정 전환 후 1년동안 회원정보 수집 및 이용에 대한
재동의를 하지 않으신 관계로 개인정보가 삭제되었습니다.
(참조 : RISS 이용약관 및 개인정보처리방침)
신규회원으로 가입하여 이용 부탁 드리며, 추가 문의는 고객센터로 연락 바랍니다.
- 기존 아이디 재사용 불가
휴면계정 안내
RISS는 [표준개인정보 보호지침]에 따라 2년을 주기로 개인정보 수집·이용에 관하여 (재)동의를 받고 있으며, (재)동의를 하지 않을 경우, 휴면계정으로 전환됩니다.
(※ 휴면계정은 원문이용 및 복사/대출 서비스를 이용할 수 없습니다.)
휴면계정으로 전환된 후 1년간 회원정보 수집·이용에 대한 재동의를 하지 않을 경우, RISS에서 자동탈퇴 및 개인정보가 삭제처리 됩니다.
고객센터 1599-3122
ARS번호+1번(회원가입 및 정보수정)